Notably, upon inhibiting FOXO3 by the small molecular weight compound repaglinide, the binding of FOXO3 to the LUM promoter was attenuated, abrogating the FOXO3-dependent lumican expression and decreasing neuroblastoma cell 2D- and 3D-migration [62]. Here, FOXO3 is linked to neuroblastoma.